Riverstone - RHB Invest 2024-11-13: Growth Remains Intact; Maintain BUY

• Post results briefing, we are upbeat on Riverstone. Its growth prospects remain intact, premised on the recovery of global semiconductor sales and improving market dynamics within the healthcare glove industry.
• - Read this at SGinvestors.io -

Key operating metrics.

• To recap, Riverstone’s cleanroom glove (CG) ASPs inched up to US$94/1,000 pieces from US$90/1000 pieces. Healthcare glove (HG) ASPs rose to US$28.50, up from US$26-27, on a favourable product mix.
• Moving forward, we expect cleanroom glove ASP to be flattish or see a mild increase as the bulk of the price has been locked in on a periodic basis. Healthcare glove is expected to remain rangebound as well, due to the higher product mix towards the generic segment (driven by industry recovery trend and trade diversion).
• - Read this at SGinvestors.io -

Margins.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2026-02-20 Riverstone - Holding Steady.

Previous report by RHB:
2025-11-11 Riverstone - Cooling Off After The Rally; Downgrade To NEUTRAL.

Price targets by other brokers at Riverstone Target Prices.

Listing of research reports at Riverstone Analyst Reports.

Relevant links:
Riverstone Share Price History,
Riverstone Announcements,
Riverstone Dividend Payout Dates & Corporate Actions,
Riverstone News